price aug usd
revenu usdm
strong de-risk wari
buy rate agil reflect view compani opportun
growth margin expans capit deploy peer
compani meaning beat dbe consensu forecast plu deploy signif-
icant capit support thesi
thing like
 rais guid strength agil rais organ sale
growth guid rang compani also rais
adj ep guid rang mid-
 strong organ sale growth beat july-end quarter organ sale
growth meaning outpac forecast consensu
out-performance driven acg dgg busi
report core growth versu dbe forecast
respect growth acg dgg broad-bas
across custom end market region product categori notabl
agil report doubl digit growth consum servic
busi adj ep came well consensus-lik
forecast
 biopharma strength among small larg molecul custom
robust pharma biotech end market growth acceler
meaning prior quarter view impress
particularli light challeng prior year compar
manag note strength among small larg molecul custom
also report sequenti quarter improv among china gener
thing cautiou
longer ramp nasd previous expect revis
growth rate dgg segment compani commun
longer ramp time oligo api manufactur busi
previous model
 china stabl lack visibl growth key market agil
china core sale growth deceler prior
deutsch bank seek busi compani cover research report thu investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis disclosur analyst certif locat
distribut gmt
quarter manag attribut weak continu pressur
china food test market challeng prior year compar
posit front acg busi report high-teen growth china
quarter overal believ headwind china persist
dampen compani overal growth pictur
guid global macro pictur soften agil oct-end
organ sale growth guid rang came dbe
consensu anticip sequenti quarter deceler
reflect tough compar overal macro weaken reflect global
pmi impact lsag coupl deceler nasd
busi moder double-digit growth report acg
dgg busi
pt
lower pt reflect overal reduct peer multipl price
target agil reflect enterpris valu use project level debt
cash ebitda ex option estim ttm end
multipl in-lin life scienc tool peer group median ev/ftm ebitda ex
period end incom expens expens incom share share ep dilut per sale oper cash flowoper cash cash revenu
period end equival st current equip intang asset cash lt sharehold equityaccount matur lt current liabil sh equiti minor august
price current end previou trade session unless otherwis indic sourc local exchang via reuter bloomberg vendor
inform sourc deutsch bank subject compani sourc disclosur pertain recommend estim made secur primari
subject research pleas see recent publish compani report visit global disclosur look-up page websit http //research db com/research/disclosures/
companysearch asid within report import risk conflict disclosur also found investor
strongli encourag review inform invest
import disclosur requir regul
disclosur mark asterisk may also requir least one jurisdict addit unit state see
import disclosur requir non-u regul explanatori note
deutsch bank and/or affili make market equiti secur issu compani
deutsch bank and/or affili own one percent class common equiti secur compani
calcul comput method requir us law
deutsch bank and/or affili receiv compens compani provis invest
bank financi advisori servic within past year
import disclosur requir non-u regul
